The National Institute for Health and Care Excellence (NICE) on Friday approved ribociclib – also known as Kisqali – for routine use by the NHS. The Independent
Monday, 1 March 2021
Life-extending drug for incurable breast cancer approved for NHS use
Life-extending drug for incurable breast cancer approved for NHS use A drug which could help extend the lives of thousands of women with incurable advanced breast cancer has been approved for NHS use.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment